Shopping Cart 0
Cart Subtotal
AED 0

Global Immortalized Cell Line Market Research Report - Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 16332

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 22938

Details

Introduction

Immortalized cell lines are either tumorous cells that do not stop dividing or cells that have been artificially manipulated to proliferate indefinitely and can, thus, be cultured over several generations. HepaRG and Hep G2 cell lines are most frequently used for toxicity studies among the currently available human hepatic cell lines.

The immortalized cell line plays a vital role in cell biology while studying multicellular organisms and their biochemistry. The demand for immortalized cell lines is increasing and so as the applications. The increasing adoption of immortalized cell lines in stem cell therapy drives the growth of the market.

Besides, the increasing awareness regarding the use of cell lines in healthcare, rising vaccines production, increasing application of cell lines in cancer therapy, and use of innovative technology for cell lines have fueled the growth of the market. On the other hand, the high cost of equipment and difficulties in developing a stable and authentic strain have restrained the growth of the immortalized cell line market.

Moreover, continuous cell lines are widely used by numerous pharmaceutical and biotech-based companies as a specimen for testing the drug efficacy. Due to this, there is a reduction in the use of gnotobiotic animals such as mice, rabbits, and monkeys, among others. Moreover, as these cell lines have a long shelf life and can be easily preserved via cryopreservation and lyophilization techniques, several biotech and pharmaceutical companies are preferring them over other media cultures for performing their R&D activities. For instance, as per a report published by the Department of Pharmaceutical Sciences and Bio Manufacturing Research Institute and Technology Enterprises (BRITE), in 2014, around 1.3 USD billion capital was invested in new pharmaceuticals for drug discovery through cell line culture.

The global immortalized cell line market is segmented based on method, application, and end-user.

Based on method, the market is further segmented into virus induction, HTERT expression, inactivation of tumor, suppression genes, and others.

Based on application, the market is segmented into diagnostics, drug discovery, vaccine production, tissue engineering and regenerative medicine, and others.

Based on end-user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, and research laboratories.

The global immortalized cell line market was valued at USD 2,421.34 million in 2017 and is expected to register a CAGR of 9.30% during the forecast period from 2018 to 2023.

Key Players

Lonza Group AG, Corning Incorporated, Thermo Fisher Scientific, Selexis SA, Valneva, European Collection of Authenticated Cell Cultures (ECACC), Sartorius AG, ATCC (American Type Culture Collection Inc.), Merck KGaA, and Wuxi App Tec, and others

Study objectives

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global immortalized cell line market

To provide insights into factors influencing and affecting the market growth

To provide historical and forecast revenue of market segments and sub-segments with respect to countries

To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global immortalized cell line market

To provide a detailed analysis of the value chain and supply chain of the global immortalized cell line market

Target Audience

Pharmaceutical Companies

Research and Development (R&D) Companies

Market Research and Consulting Service Providers

Potential Investors

Key Findings

The global immortalized cell line market is expected to reach USD 4,105.62 million by 2023 at a CAGR of 9.30% from 2018 to 2023

On the basis of method, virus induction accounted for the largest market share of 39.9% in the year 2017 and was valued at USD 965.97 million in the same year

On the basis of application, diagnostic accounted for the largest market share of 32.1% in 2017

The Americas holds the largest share of the global immortalized cell line market which is expected to reach USD 1,505.38 million by 2023

Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 10.04 % from 2018 to 2023

Regional Analysis

Americas

o North America

? US

? Canada

o South America

Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

Asia-Pacific

o Japan

o China

o India

o Australia

o Republic of Korea

o Rest of Asia-Pacific

Middle East & Africa

o Middle East

o Africa

READ MORE

Table Of Content

Scope

Table of Contents:

 

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Scope of Study

3.2 Research Objective

3.3 List of Assumptions

3.4 Market Structure

4 Research Methodology

4.1 Research Process

4.2 Primary Research

4.3 Secondary Research

4.4 Market Size Estimation

4.5 Forecast Model

5 Market Dynamics

5.1 Introduction

5.2 Drivers

5.2.1 Increasing application in biotech & pharmaceutical companies and hospitals

5.2.2 Growing number of patients in need of organ transplantation

5.2.3 Rise in the patient population affected by cancer

5.3 Restraints

5.3.1 High cost of equipment

5.3.2 Developing stable and authentic cell lines

5.4 Opportunities

5.4.1 Entering untapped markets

5.4.2 Increasing use of cell line culture in cancer and stem cell research

6 Market Factor Analysis

6.1 Porters Five Forces Analysis

6.1.1 Bargaining Power of Suppliers

6.1.2 Bargaining Power of Buyers

6.1.3 Threat of New Entrants

6.1.4 Threat of Substitutes

6.1.5 Intensity of Rivalry

6.2 Supply chain analysis

6.2.1 R&D

6.2.2 Manufacturing

6.2.3 Distribution & Sales

6.2.4 Post-Sales Monitoring

6.3 Investment Opportunities

6.4 Pricing Analysis

7 Global Immortalized Cell Line Market, by Method

7.1 Overview

7.1.1 Virus Induction

7.1.2 HTERT Expression

7.1.3 Inactivation of Tumour Suppression Genes

7.1.4 Others

8 Global Immortalized Cell Line Market, by Application

8.1 Overview

8.1.1 Diagnostics

8.1.2 Drug Discovery

8.1.3 Vaccine Production

8.1.4 Tissue Engineering and Regenerative Medicines

8.1.5 Others

9 Global Immortalized Cell Line Market, by End-user

9.1 Overview

9.1.1 Introduction

9.1.2 Pharmaceutical and Biopharmaceutical Companies

9.1.3 Contract Research Organizations

9.1.4 Research Laboratories

10 Global Immortalized Cell Line Market, By Region

10.1 Overview

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 South Korea

10.4.5 Rest of Asia-Pacific

10.5 Middle East and Africa

10.5.1 Middle East

10.5.2 Africa

11 Competitive Landscape

11.1 Company Market Share Analysis

11.1.1 Introduction

11.2 Competitive Landscape

11.2.1 Introduction

11.3 Key Developments

12 Company Profiles

12.1 Thermo Fisher Scientific

12.1.1 Company Overview

12.1.2 Financial Overview

12.1.3 Products Offering

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.1.6 Key Strategy

12.2 ATCC (American Type Culture Collection Inc.)

12.2.1 Company Overview

12.2.2 Financial Overview

12.2.3 Products Offering

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.2.6 Key Strategy

12.3 Valneva

12.3.1 Company Overview

12.3.2 Financial Overview

12.3.3 Products Offering

12.3.4 1.3.4 Key Developments

12.3.5 SWOT Analysis

12.3.6 Key Strategy

12.4 Sartorius AG

12.4.1 Company Overview

12.4.2 Financial Overview

12.4.3 Products Offering

12.4.4 Key Developments

12.4.5 SWOT Analysis

12.4.6 Key Strategy

12.5 Lonza Group, AG

12.5.1 Company Overview

12.5.2 Financial Overview

12.5.3 Products Offering

12.5.4 Key Developments

12.5.5 Swot Analysis

12.5.6 Key Strategy

12.6 Merck KGaA

12.6.1 Company Overview

12.6.2 Financial Overview

12.6.3 Products Offering

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.6.6 Key Strategy

12.7 Selexis SA

12.7.1 Company Overview

12.7.2 Financial Overview

12.7.3 Products Offering

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.7.6 Key Strategy

12.8 Wuxi App Tec

12.8.1 Company Overview

12.8.2 Financial Overview

12.8.3 Products Offering

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.8.6 Key Strategy

12.9 European Collection of Authenticated Cell Cultures (ECACC)

12.9.1 Company Overview

12.9.2 Financial Overview

12.9.3 Products Offering

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.9.6 Key Strategy

12.1 Corning Incorporated

12.10.1 Company Overview

12.10.2 Financial Overview

12.10.3 Products Offering

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.10.6 Key Strategy

13 Appendix

13.1 Discussion Blue Print


List Of Figure

List of Figures:

 

FIGURE 1 GLOBAL IMMORTALIZED CELL LINE MARKET: MARKET STRUCTURE

FIGURE 2 RESEARCH PROCESS OF MRFR

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH

FIGURE 4 PORTERS FIVE FORCES ANALYSIS OF GLOBAL IMMORTALIZED CELL LINE MARKET

FIGURE 5 SUPPLY CHAIN: GLOBAL IMMORTALIZED CELL LINE MARKET

FIGURE 6 GLOBAL IMMORTALIZED CELL LINE MARKET, BY METHOD 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL IMMORTALIZED CELL LINE MARKET, BY END-USERS 2017 & 2023 (USD MILLION)

FIGURE 9 AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2017 (%)

FIGURE 10 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2017 (%)

FIGURE 11 EUROPE: IMMORTALIZED CELL LINE MARKET SHARE, BY REGION, 2017 (% SHARE)

FIGURE 12 WESTERN EUROPE: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2017 (%)

FIGURE 13 ASIA-PACIFIC: IMMORTALIZED CELL LINE MARKET SHARE, BY COUNTRY, 2017 (%)

FIGURE 14 MIDDLE EAST AND AFRICA: IMMORTALIZED CELL LINE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 15 GLOBAL IMMORTALIZED CELL LINE MARKET, MARKET SHARE ANALYSIS 2017 (%)

FIGURE 16 GLOBAL IMMORTALIZED CELL LINE MARKET COMPETITIVE LANDSCAPE (%)


List Of Table

List of Tables:

 

TABLE 1 MARKET SYNOPSIS

TABLE 2 LIST OF ASSUMPTIONS

TABLE 3 GLOBAL IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 4 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 5 GLOBAL IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 6 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY REGION 2015-2023 (USD MILLION)

TABLE 7 GLOBAL IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY REGION 2015-2023 (USD MILLION)

TABLE 8 GLOBAL IMMORTALIZED CELL LINE MARKET FOR INACTIVATION OF TUMOUR SUPPRESSION GENES, BY REGION 2015-2023 (USD MILLION)

TABLE 9 GLOBAL IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 10 GLOBAL IMMORTALIZED CELL LINE MARKET FOR DIAGNOSTICS, BY REGION 2015-2023 (USD MILLION)

TABLE 11 GLOBAL IMMORTALIZED CELL LINE MARKET FOR DRUG DISCOVERY, BY REGION 2015-2023 (USD MILLION)

TABLE 12 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VACCINE PRODUCTION, BY REGION 2015-2023 (USD MILLION)

TABLE 13 GLOBAL IMMORTALIZED CELL LINE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION 2015-2023 (USD MILLION)

TABLE 14 GLOBAL IMMORTALIZED CELL LINE MARKET, BY END-USERS 2015-2023 (USD MILLION)

TABLE 15 GLOBAL IMMORTALIZED CELL LINE MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION 2015-2023 (USD MILLION)

TABLE 16 GLOBAL IMMORTALIZED CELL LINE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION 2015-2023 (USD MILLION)

TABLE 17 GLOBAL IMMORTALIZED CELL LINE MARKET FOR RESEARCH LABORATORIES, BY REGION 2015-2023 (USD MILLION)

TABLE 18 GLOBAL IMMORTALIZED CELL LINE MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 19 GLOBAL IMMORTALIZED CELL LINE MARKET, BY REGION 2017 & 2023 (USD MILLION)

TABLE 20 AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 21 AMERICAS IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 22 AMERICAS IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 23 AMERICAS IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 24 AMERICAS IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 25 AMERICAS IMMORTALIZED CELL LINE MARKET, BY END-USERS 2015-2023 (USD MILLION)

TABLE 26 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 27 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 28 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 29 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 30 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 31 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 32 US IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 33 US IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 34 US IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 35 US IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 36 US IMMORTALIZED CELL LINE MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 37 CANADA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USDMILLION)

TABLE 38 CANADA IMMORTALIZED CELL LINE MARKET FOR VIRCANADA INDUCTION, BY TYPE 2015-2023 (USDMILLION)

TABLE 39 CANADA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USDMILLION)

TABLE 40 CANADA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USDMILLION)

TABLE 41 CANADA IMMORTALIZED CELL LINE MARKET, BY END-USER 2015-2023 (USDMILLION)

TABLE 42 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 43 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET FOR VIRSOUTH AMERICA INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 44 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 45 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 46 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 47 EUROPE IMMORTALIZED CELL LINE MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 48 EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 49 EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 50 EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 51 EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 52 EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 53 WESTERN EUROPE: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2015-2023 (USD MILLION)

TABLE 54 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 55 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 56 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 57 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 58 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 59 GERMANY IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 60 GERMANY IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 61 GERMANY IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 62 GERMANY IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 63 GERMANY IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 64 FRANCE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 65 FRANCE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 66 FRANCE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 67 FRANCE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 68 FRANCE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 69 UK IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 70 UK IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 71 UK IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 72 UK IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 73 UK IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 74 ITALY IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 75 ITALY IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 76 ITALY IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 77 ITALY IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 78 ITALY IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 79 SPAIN IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 80 SPAIN IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 81 SPAIN IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 82 SPAIN IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 83 SPAIN IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 84 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 85 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 86 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 87 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 88 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 89 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 90 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 91 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 92 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 93 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 94 ASIA-PACIFIC: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2015-2023 (USD MILLION)

TABLE 95 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 96 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 97 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 98 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 99 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 100 JAPAN IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 101 JAPAN IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 102 JAPAN IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 103 JAPAN IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 104 JAPAN IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 105 CHINA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 106 CHINA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 107 CHINA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 108 CHINA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 109 CHINA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 110 INDIA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 111 INDIA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 112 INDIA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 113 INDIA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 114 INDIA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 115 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 116 SOUTH KOREA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 117 SOUTH KOREA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 118 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 119 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 120 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 121 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 122 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 123 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 124 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 125 MIDDLE EAST AND AFRICA: IMMORTALIZED CELL LINE MARKET, BY REGION, 2015-2023 (USD MILLION)

TABLE 126 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 127 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 128 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 129 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 130 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 131 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 132 MIDDLE EAST IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 133 MIDDLE EAST IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 134 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 135 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 136 AFRICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 137 AFRICA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 138 AFRICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 139 AFRICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 140 AFRICA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 141 GLOBAL IMMORTALIZED CELL LINE MARKET: KEY DEVELOPMENT

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Thermo Fisher Scientific, ATCC (American Type Culture Collection Inc.), Valneva, Sartorius AG, Lonza Group, AG, Merck KGaA , Selexis SA, Wuxi App Tec, European Collection of Authenticated Cell Cultures (ECACC), Corning Incorporated

Company Profile

Company Profile Title

Introduction

Immortalized cell lines are either tumorous cells that do not stop dividing or cells that have been artificially manipulated to proliferate indefinitely and can, thus, be cultured over several generations. HepaRG and Hep G2 cell lines are most frequently used for toxicity studies among the currently available human hepatic cell lines.

The immortalized cell line plays a vital role in cell biology while studying multicellular organisms and their biochemistry. The demand for immortalized cell lines is increasing and so as the applications. The increasing adoption of immortalized cell lines in stem cell therapy drives the growth of the market.

Besides, the increasing awareness regarding the use of cell lines in healthcare, rising vaccines production, increasing application of cell lines in cancer therapy, and use of innovative technology for cell lines have fueled the growth of the market. On the other hand, the high cost of equipment and difficulties in developing a stable and authentic strain have restrained the growth of the immortalized cell line market.

Moreover, continuous cell lines are widely used by numerous pharmaceutical and biotech-based companies as a specimen for testing the drug efficacy. Due to this, there is a reduction in the use of gnotobiotic animals such as mice, rabbits, and monkeys, among others. Moreover, as these cell lines have a long shelf life and can be easily preserved via cryopreservation and lyophilization techniques, several biotech and pharmaceutical companies are preferring them over other media cultures for performing their R&D activities. For instance, as per a report published by the Department of Pharmaceutical Sciences and Bio Manufacturing Research Institute and Technology Enterprises (BRITE), in 2014, around 1.3 USD billion capital was invested in new pharmaceuticals for drug discovery through cell line culture.

The global immortalized cell line market is segmented based on method, application, and end-user.

Based on method, the market is further segmented into virus induction, HTERT expression, inactivation of tumor, suppression genes, and others.

Based on application, the market is segmented into diagnostics, drug discovery, vaccine production, tissue engineering and regenerative medicine, and others.

Based on end-user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, and research laboratories.

The global immortalized cell line market was valued at USD 2,421.34 million in 2017 and is expected to register a CAGR of 9.30% during the forecast period from 2018 to 2023.

Key Players

Lonza Group AG, Corning Incorporated, Thermo Fisher Scientific, Selexis SA, Valneva, European Collection of Authenticated Cell Cultures (ECACC), Sartorius AG, ATCC (American Type Culture Collection Inc.), Merck KGaA, and Wuxi App Tec, and others

Study objectives

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global immortalized cell line market

To provide insights into factors influencing and affecting the market growth

To provide historical and forecast revenue of market segments and sub-segments with respect to countries

To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global immortalized cell line market

To provide a detailed analysis of the value chain and supply chain of the global immortalized cell line market

Target Audience

Pharmaceutical Companies

Research and Development (R&D) Companies

Market Research and Consulting Service Providers

Potential Investors

Key Findings

The global immortalized cell line market is expected to reach USD 4,105.62 million by 2023 at a CAGR of 9.30% from 2018 to 2023

On the basis of method, virus induction accounted for the largest market share of 39.9% in the year 2017 and was valued at USD 965.97 million in the same year

On the basis of application, diagnostic accounted for the largest market share of 32.1% in 2017

The Americas holds the largest share of the global immortalized cell line market which is expected to reach USD 1,505.38 million by 2023

Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 10.04 % from 2018 to 2023

Regional Analysis

Americas

o North America

? US

? Canada

o South America

Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

Asia-Pacific

o Japan

o China

o India

o Australia

o Republic of Korea

o Rest of Asia-Pacific

Middle East & Africa

o Middle East

o Africa

READ MORE

Scope

Table of Contents:

 

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Scope of Study

3.2 Research Objective

3.3 List of Assumptions

3.4 Market Structure

4 Research Methodology

4.1 Research Process

4.2 Primary Research

4.3 Secondary Research

4.4 Market Size Estimation

4.5 Forecast Model

5 Market Dynamics

5.1 Introduction

5.2 Drivers

5.2.1 Increasing application in biotech & pharmaceutical companies and hospitals

5.2.2 Growing number of patients in need of organ transplantation

5.2.3 Rise in the patient population affected by cancer

5.3 Restraints

5.3.1 High cost of equipment

5.3.2 Developing stable and authentic cell lines

5.4 Opportunities

5.4.1 Entering untapped markets

5.4.2 Increasing use of cell line culture in cancer and stem cell research

6 Market Factor Analysis

6.1 Porters Five Forces Analysis

6.1.1 Bargaining Power of Suppliers

6.1.2 Bargaining Power of Buyers

6.1.3 Threat of New Entrants

6.1.4 Threat of Substitutes

6.1.5 Intensity of Rivalry

6.2 Supply chain analysis

6.2.1 R&D

6.2.2 Manufacturing

6.2.3 Distribution & Sales

6.2.4 Post-Sales Monitoring

6.3 Investment Opportunities

6.4 Pricing Analysis

7 Global Immortalized Cell Line Market, by Method

7.1 Overview

7.1.1 Virus Induction

7.1.2 HTERT Expression

7.1.3 Inactivation of Tumour Suppression Genes

7.1.4 Others

8 Global Immortalized Cell Line Market, by Application

8.1 Overview

8.1.1 Diagnostics

8.1.2 Drug Discovery

8.1.3 Vaccine Production

8.1.4 Tissue Engineering and Regenerative Medicines

8.1.5 Others

9 Global Immortalized Cell Line Market, by End-user

9.1 Overview

9.1.1 Introduction

9.1.2 Pharmaceutical and Biopharmaceutical Companies

9.1.3 Contract Research Organizations

9.1.4 Research Laboratories

10 Global Immortalized Cell Line Market, By Region

10.1 Overview

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 South Korea

10.4.5 Rest of Asia-Pacific

10.5 Middle East and Africa

10.5.1 Middle East

10.5.2 Africa

11 Competitive Landscape

11.1 Company Market Share Analysis

11.1.1 Introduction

11.2 Competitive Landscape

11.2.1 Introduction

11.3 Key Developments

12 Company Profiles

12.1 Thermo Fisher Scientific

12.1.1 Company Overview

12.1.2 Financial Overview

12.1.3 Products Offering

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.1.6 Key Strategy

12.2 ATCC (American Type Culture Collection Inc.)

12.2.1 Company Overview

12.2.2 Financial Overview

12.2.3 Products Offering

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.2.6 Key Strategy

12.3 Valneva

12.3.1 Company Overview

12.3.2 Financial Overview

12.3.3 Products Offering

12.3.4 1.3.4 Key Developments

12.3.5 SWOT Analysis

12.3.6 Key Strategy

12.4 Sartorius AG

12.4.1 Company Overview

12.4.2 Financial Overview

12.4.3 Products Offering

12.4.4 Key Developments

12.4.5 SWOT Analysis

12.4.6 Key Strategy

12.5 Lonza Group, AG

12.5.1 Company Overview

12.5.2 Financial Overview

12.5.3 Products Offering

12.5.4 Key Developments

12.5.5 Swot Analysis

12.5.6 Key Strategy

12.6 Merck KGaA

12.6.1 Company Overview

12.6.2 Financial Overview

12.6.3 Products Offering

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.6.6 Key Strategy

12.7 Selexis SA

12.7.1 Company Overview

12.7.2 Financial Overview

12.7.3 Products Offering

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.7.6 Key Strategy

12.8 Wuxi App Tec

12.8.1 Company Overview

12.8.2 Financial Overview

12.8.3 Products Offering

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.8.6 Key Strategy

12.9 European Collection of Authenticated Cell Cultures (ECACC)

12.9.1 Company Overview

12.9.2 Financial Overview

12.9.3 Products Offering

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.9.6 Key Strategy

12.1 Corning Incorporated

12.10.1 Company Overview

12.10.2 Financial Overview

12.10.3 Products Offering

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.10.6 Key Strategy

13 Appendix

13.1 Discussion Blue Print


List Of Figure

List of Figures:

 

FIGURE 1 GLOBAL IMMORTALIZED CELL LINE MARKET: MARKET STRUCTURE

FIGURE 2 RESEARCH PROCESS OF MRFR

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH

FIGURE 4 PORTERS FIVE FORCES ANALYSIS OF GLOBAL IMMORTALIZED CELL LINE MARKET

FIGURE 5 SUPPLY CHAIN: GLOBAL IMMORTALIZED CELL LINE MARKET

FIGURE 6 GLOBAL IMMORTALIZED CELL LINE MARKET, BY METHOD 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL IMMORTALIZED CELL LINE MARKET, BY END-USERS 2017 & 2023 (USD MILLION)

FIGURE 9 AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2017 (%)

FIGURE 10 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2017 (%)

FIGURE 11 EUROPE: IMMORTALIZED CELL LINE MARKET SHARE, BY REGION, 2017 (% SHARE)

FIGURE 12 WESTERN EUROPE: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2017 (%)

FIGURE 13 ASIA-PACIFIC: IMMORTALIZED CELL LINE MARKET SHARE, BY COUNTRY, 2017 (%)

FIGURE 14 MIDDLE EAST AND AFRICA: IMMORTALIZED CELL LINE MARKET SHARE, BY REGION, 2017 (%)

FIGURE 15 GLOBAL IMMORTALIZED CELL LINE MARKET, MARKET SHARE ANALYSIS 2017 (%)

FIGURE 16 GLOBAL IMMORTALIZED CELL LINE MARKET COMPETITIVE LANDSCAPE (%)


List Of Table

List of Tables:

 

TABLE 1 MARKET SYNOPSIS

TABLE 2 LIST OF ASSUMPTIONS

TABLE 3 GLOBAL IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 4 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 5 GLOBAL IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 6 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY REGION 2015-2023 (USD MILLION)

TABLE 7 GLOBAL IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY REGION 2015-2023 (USD MILLION)

TABLE 8 GLOBAL IMMORTALIZED CELL LINE MARKET FOR INACTIVATION OF TUMOUR SUPPRESSION GENES, BY REGION 2015-2023 (USD MILLION)

TABLE 9 GLOBAL IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 10 GLOBAL IMMORTALIZED CELL LINE MARKET FOR DIAGNOSTICS, BY REGION 2015-2023 (USD MILLION)

TABLE 11 GLOBAL IMMORTALIZED CELL LINE MARKET FOR DRUG DISCOVERY, BY REGION 2015-2023 (USD MILLION)

TABLE 12 GLOBAL IMMORTALIZED CELL LINE MARKET FOR VACCINE PRODUCTION, BY REGION 2015-2023 (USD MILLION)

TABLE 13 GLOBAL IMMORTALIZED CELL LINE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION 2015-2023 (USD MILLION)

TABLE 14 GLOBAL IMMORTALIZED CELL LINE MARKET, BY END-USERS 2015-2023 (USD MILLION)

TABLE 15 GLOBAL IMMORTALIZED CELL LINE MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION 2015-2023 (USD MILLION)

TABLE 16 GLOBAL IMMORTALIZED CELL LINE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION 2015-2023 (USD MILLION)

TABLE 17 GLOBAL IMMORTALIZED CELL LINE MARKET FOR RESEARCH LABORATORIES, BY REGION 2015-2023 (USD MILLION)

TABLE 18 GLOBAL IMMORTALIZED CELL LINE MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 19 GLOBAL IMMORTALIZED CELL LINE MARKET, BY REGION 2017 & 2023 (USD MILLION)

TABLE 20 AMERICAS IMMORTALIZED CELL LINE MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 21 AMERICAS IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 22 AMERICAS IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 23 AMERICAS IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 24 AMERICAS IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 25 AMERICAS IMMORTALIZED CELL LINE MARKET, BY END-USERS 2015-2023 (USD MILLION)

TABLE 26 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 27 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 28 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 29 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 30 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 31 NORTH AMERICAS IMMORTALIZED CELL LINE MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 32 US IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 33 US IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 34 US IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 35 US IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 36 US IMMORTALIZED CELL LINE MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 37 CANADA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USDMILLION)

TABLE 38 CANADA IMMORTALIZED CELL LINE MARKET FOR VIRCANADA INDUCTION, BY TYPE 2015-2023 (USDMILLION)

TABLE 39 CANADA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USDMILLION)

TABLE 40 CANADA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USDMILLION)

TABLE 41 CANADA IMMORTALIZED CELL LINE MARKET, BY END-USER 2015-2023 (USDMILLION)

TABLE 42 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 43 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET FOR VIRSOUTH AMERICA INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 44 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 45 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 46 SOUTH AMERICA IMMORTALIZED CELL LINE MARKET, BY END-USER 2015-2023 (USD MILLION)

TABLE 47 EUROPE IMMORTALIZED CELL LINE MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 48 EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 49 EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 50 EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 51 EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 52 EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 53 WESTERN EUROPE: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2015-2023 (USD MILLION)

TABLE 54 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 55 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 56 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 57 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 58 WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 59 GERMANY IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 60 GERMANY IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 61 GERMANY IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 62 GERMANY IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 63 GERMANY IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 64 FRANCE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 65 FRANCE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 66 FRANCE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 67 FRANCE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 68 FRANCE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 69 UK IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 70 UK IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 71 UK IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 72 UK IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 73 UK IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 74 ITALY IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 75 ITALY IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 76 ITALY IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 77 ITALY IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 78 ITALY IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 79 SPAIN IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 80 SPAIN IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 81 SPAIN IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 82 SPAIN IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 83 SPAIN IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 84 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 85 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 86 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 87 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 88 REST OF WESTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 89 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 90 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 91 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 92 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 93 EASTERN EUROPE IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 94 ASIA-PACIFIC: IMMORTALIZED CELL LINE MARKET, BY COUNTRY, 2015-2023 (USD MILLION)

TABLE 95 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 96 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 97 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 98 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 99 ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 100 JAPAN IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 101 JAPAN IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 102 JAPAN IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 103 JAPAN IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 104 JAPAN IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 105 CHINA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 106 CHINA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 107 CHINA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 108 CHINA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 109 CHINA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 110 INDIA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 111 INDIA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 112 INDIA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 113 INDIA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 114 INDIA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 115 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 116 SOUTH KOREA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 117 SOUTH KOREA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 118 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 119 SOUTH KOREA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 120 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 121 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 122 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 123 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 124 REST OF ASIA-PACIFIC IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 125 MIDDLE EAST AND AFRICA: IMMORTALIZED CELL LINE MARKET, BY REGION, 2015-2023 (USD MILLION)

TABLE 126 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 127 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 128 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 129 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 130 MIDDLE EAST AND AFRICA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 131 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 132 MIDDLE EAST IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 133 MIDDLE EAST IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 134 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 135 MIDDLE EAST IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 136 AFRICA IMMORTALIZED CELL LINE MARKET, BY METHOD 2015-2023 (USD MILLION)

TABLE 137 AFRICA IMMORTALIZED CELL LINE MARKET FOR VIRUS INDUCTION, BY TYPE 2015-2023 (USD MILLION)

TABLE 138 AFRICA IMMORTALIZED CELL LINE MARKET FOR HTERT EXPRESSION, BY TYPE 2015-2023 (USD MILLION)

TABLE 139 AFRICA IMMORTALIZED CELL LINE MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 140 AFRICA IMMORTALIZED CELL LINE MARKET, BY END USERS 2015-2023 (USD MILLION)

TABLE 141 GLOBAL IMMORTALIZED CELL LINE MARKET: KEY DEVELOPMENT

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Thermo Fisher Scientific, ATCC (American Type Culture Collection Inc.), Valneva, Sartorius AG, Lonza Group, AG, Merck KGaA , Selexis SA, Wuxi App Tec, European Collection of Authenticated Cell Cultures (ECACC), Corning Incorporated